Filing Flows › Cryo Cell International (CCEL) › Who owns the stock
Who owns Cryo Cell International (CCEL) stock
13 funds reported Cryo Cell International (CCEL) shares in their latest 13F filings, worth $2.6M in all. The largest holder is SFI Advisors, LLC ($694K). Last quarter 6 funds added to their stakes and 3 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| SFI Advisors, LLC | 165,300 | $694K | unchanged | 2026-09-30 |
| Vanguard Capital Management LLC | 164,976 | $526K | increase | 2026-06-30 |
| Vanguard Group | 150,991 | $519K | unchanged | 2025-12-31 |
| MassMutual Private Wealth & Trust, FSB | 111,035 | $466K | unchanged | 2026-09-30 |
| Geode Capital Management, LLC | 46,273 | $148K | increase | 2026-06-30 |
| Vanguard Fiduciary Trust | 23,346 | $74K | unchanged | 2026-06-30 |
| FMR LLC | 20,000 | $64K | new | 2026-06-30 |
| Susquehanna International Group, LLP | 14,064 | $45K | increase | 2026-06-30 |
| BlackRock | 6,696 | $21K | decrease | 2026-06-30 |
| Barclays | 4,759 | $20K | increase | 2026-09-30 |
| Osaic Holdings | 2,500 | $8K | unchanged | 2026-06-30 |
| Morgan Stanley | 605 | $2K | increase | 2026-06-30 |
| UBS Group AG | 316 | $1K | decrease | 2026-06-30 |
Cryo Cell International's latest quarter
Cryo Cell International, Q3 FY26: revenue $7.8M (0% year over year), operating margin 28.0%, net earnings $1.3M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CCEL stock?
By the latest 13F filings: SFI Advisors, LLC ($694K); Vanguard Capital Management LLC ($526K); Vanguard Group ($519K); MassMutual Private Wealth & Trust, FSB ($466K); Geode Capital Management, LLC ($148K).
What is the short interest in CCEL?
7,070 shares were sold short at the 2026-10-15 settlement, 10.19% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.